These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25749423)

  • 1. Therapeutic potential of berberine against neurodegenerative diseases.
    Jiang W; Li S; Li X
    Sci China Life Sci; 2015 Jun; 58(6):564-9. PubMed ID: 25749423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learning from berberine: Treating chronic diseases through multiple targets.
    Yao J; Kong W; Jiang J
    Sci China Life Sci; 2015 Sep; 58(9):854-9. PubMed ID: 24174332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model.
    Jiang W; Wei W; Gaertig MA; Li S; Li XJ
    PLoS One; 2015; 10(7):e0134142. PubMed ID: 26225560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.
    Feng X; Sureda A; Jafari S; Memariani Z; Tewari D; Annunziata G; Barrea L; Hassan STS; Šmejkal K; Malaník M; Sychrová A; Barreca D; Ziberna L; Mahomoodally MF; Zengin G; Xu S; Nabavi SM; Shen AZ
    Theranostics; 2019; 9(7):1923-1951. PubMed ID: 31037148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine in the Treatment of Neurodegenerative Diseases and Nanotechnology Enabled Targeted Delivery.
    Mohi-Ud-Din R; Mir RH; Wani TU; Shah AJ; Banday N; Pottoo FH
    Comb Chem High Throughput Screen; 2022; 25(4):616-633. PubMed ID: 34348611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential.
    Fan D; Liu L; Wu Z; Cao M
    Curr Neuropharmacol; 2019; 17(6):563-579. PubMed ID: 29676231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
    Sahu K; Singh S; Devi B; Singh C; Singh A
    Curr Drug Targets; 2022; 23(9):913-923. PubMed ID: 35240956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers.
    Hu S; Zhao R; Liu Y; Chen J; Zheng Z; Wang S
    Biomed Res Int; 2019; 2019():6831520. PubMed ID: 31950049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From small to big molecules: how do we prevent and delay the progression of age-related neurodegeneration?
    Ho YS; Poon DC; Chan TF; Chang RC
    Curr Pharm Des; 2012; 18(1):15-26. PubMed ID: 22211681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
    Pirillo A; Catapano AL
    Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of obesity on neurodegenerative diseases.
    Mazon JN; de Mello AH; Ferreira GK; Rezin GT
    Life Sci; 2017 Aug; 182():22-28. PubMed ID: 28583368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability.
    Zhang X; Zhang X; Wang C; Li Y; Dong L; Cui L; Wang L; Liu Z; Qiao H; Zhu C; Xing Y; Cao X; Ji Y; Zhao K
    Brain Res; 2012 Jun; 1459():61-70. PubMed ID: 22560097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms].
    Zhang Q; Li Y; Chen L
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(9):1660-5. PubMed ID: 26323125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence.
    Xu X; Yi H; Wu J; Kuang T; Zhang J; Li Q; Du H; Xu T; Jiang G; Fan G
    Biomed Pharmacother; 2021 Jan; 133():110984. PubMed ID: 33186794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation.
    Li C; Xi Y; Li S; Zhao Q; Cheng W; Wang Z; Zhong J; Niu X; Chen G
    Mol Immunol; 2015 Oct; 67(2 Pt B):444-54. PubMed ID: 26224047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E and neurodegenerative diseases.
    Ricciarelli R; Argellati F; Pronzato MA; Domenicotti C
    Mol Aspects Med; 2007; 28(5-6):591-606. PubMed ID: 17306357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed-lineage kinases: a target for the prevention of neurodegeneration.
    Wang LH; Besirli CG; Johnson EM
    Annu Rev Pharmacol Toxicol; 2004; 44():451-74. PubMed ID: 14744254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine and neurodegeneration: A review of literature.
    Ahmed T; Gilani AU; Abdollahi M; Daglia M; Nabavi SF; Nabavi SM
    Pharmacol Rep; 2015 Oct; 67(5):970-9. PubMed ID: 26398393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of berberine as a natural fungicide: biodegradation and antimicrobial mechanism.
    Li Y; Yin YM; Wang XY; Wu H; Ge XZ
    J Asian Nat Prod Res; 2018 Feb; 20(2):148-162. PubMed ID: 28534425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.